Cargando…
A general approach for the site-selective modification of native proteins, enabling the generation of stable and functional antibody–drug conjugates
Antibody–drug conjugates (ADCs) are a class of targeted therapeutics that utilize the specificity of antibodies to selectively deliver highly potent cytotoxins to target cells. Although recent years have witnessed significant interest in ADCs, problems remain with the standard linkage chemistries us...
Autores principales: | Walsh, Stephen J., Omarjee, Soleilmane, Galloway, Warren R. J. D., Kwan, Terence T.-L., Sore, Hannah F., Parker, Jeremy S., Hyvönen, Marko, Carroll, Jason S., Spring, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349026/ https://www.ncbi.nlm.nih.gov/pubmed/30774870 http://dx.doi.org/10.1039/c8sc04645j |
Ejemplares similares
-
Correction: A general approach for the site-selective modification of native proteins, enabling the generation of stable and functional antibody–drug conjugates
por: Walsh, Stephen J., et al.
Publicado: (2018) -
Sulfatase-cleavable linkers for antibody-drug conjugates
por: Bargh, Jonathan D., et al.
Publicado: (2020) -
Divinylpyrimidine reagents generate antibody–drug conjugates with excellent in vivo efficacy and tolerability
por: Walsh, Stephen J., et al.
Publicado: (2022) -
Protein modification via alkyne hydrosilylation using a substoichiometric amount of ruthenium(ii) catalyst
por: Kwan, Terence T.-L., et al.
Publicado: (2017) -
Efficient development of stable and highly functionalised peptides targeting the CK2α/CK2β protein–protein interaction
por: Iegre, Jessica, et al.
Publicado: (2019)